StockTipsArenaBeta

BUY Caplin Point Laboratories Limited — MarketSmith India

BUYCaplin Point Laboratories Limited
Caplin Point Laboratories share price target & all analyst calls

byMarketSmith IndiaHorizon: 1–3 months25 Sept 2026via LiveMint Buy-or-Sell (topic)

Entry₹2,859.5Stated
Target₹3,290
Total upside +15.06% (call closed)
Stop loss₹2,690-5.93% risk
Exit₹2,69030 Sept 2026, 12:09 pm
Stop-loss hit-5.93%
Follow MarketSmith India for new calls(13% target hit, 54 closed calls)Get alertsWatch CAPLIPOINT for new buy/sell callsGet alertsSee 1 active Short-term call on CAPLIPOINTSee 84 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 30 Sept 2026
4 supporting2 neutral0 opposing
Supports the BUY call (4)

1 advisor has an active long-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·25 Sept · 5d ago

1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·24 Sept · 6d ago

Caplin Point's Unit Gets Colombia's INVIMA GMP Compliance Nod for Oncology Drugs

NewsGoogle News·5 Sept · 4w ago

(opens in new tab)

Caplin Point Subsidiary Gets Colombian GMP Certification

NewsGoogle News·1 Sept · 4w ago

(opens in new tab)
Neutral / worth noting (2)

Caplin Point Labs schedules AGM with ₹8 per share dividend payout

NewsGoogle News·4 Sept · 4w ago

(opens in new tab)

Caplin Point Laboratories: AGM Details and ₹8 Dividend

NewsGoogle News·3 Sept · 4w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Caplin Point Laboratories

All analyst calls on Caplin Point Laboratories

More from MarketSmith India

Every call and its outcome